Advertisement


Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

2018 Cancer Survivorship Symposium: Advancing Care and Research

Advertisement

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).



Related Videos

Survivorship

Carrie R. Howell, PhD, on Reducing Risks for Childhood Cancer Survivors: Trial Results

Carrie R. Howell, PhD, of St. Jude Children’s Research Hospital, discusses study findings on a web-based exercise intervention for adolescent survivors, who are at increased risk for obesity and metabolic syndrome. The program was designed to improve fitness, cognition, and quality of life (Abstract 102).

Supportive Care
Survivorship

Christopher J. Recklitis, PhD, MPH, on Sexual Aids and Supportive Care: Study Findings

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, discusses a study investigating the availability of supportive care sexual aids and resources for cancer survivors at U.S. cancer centers (Abstract 134).

Survivorship

Christopher J. Recklitis, PhD, MPH, on Mental Health in Cancer Survivors

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, summarizes two key papers on mental health: suicide risk among survivors of head and neck cancer vs other types of cancer; and the fear of cancer recurrence—its associations with mental health status and individual characteristics among cancer survivors (Abstract 146).

Geriatric Oncology
Survivorship

Arti Hurria, MD, on Survivorship Care for the Aging Population

Arti Hurria, MD, of the City of Hope, discusses ways to incorporate the principles of geriatrics into oncology care and offer targeted interventions for older survivors.

Colorectal Cancer
Survivorship
Symptom Management

David Baraghoshi, on Colorectal Cancer and Cardiovascular Disease Risk

David Baraghoshi, of the Huntsman Cancer Institute at the University of Utah, discusses an assessment of cardiovascular risk more than 10 years after diagnosis for colorectal cancer survivors compared with a cancer-free general population cohort (Abstract 113).

Advertisement

Advertisement




Advertisement